The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pharmacokinetics-Global Market Insights and Sales Trends 2024
Synopsis
Pharmacokinetics is a branch of pharmacology dedicated to determining the fate of substances administered to a living organism.
The global Pharmacokinetics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pharmacokinetics in various end use industries. The expanding demands from the Oncology, Cardiovascular Diseases, Infectious Diseases and Autoimmune Diseases, are propelling Pharmacokinetics market. Noncompartmental Methods, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Compartmental Methods segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmacokinetics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmacokinetics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmacokinetics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmacokinetics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmacokinetics covered in this report include Charles River Laboratories, Covance, Cyprotex, Drumetix Laboratories, Eurofins Scientific, GVK Biosciences, LGC, Parexel and Pharmoptima, etc.
The global Pharmacokinetics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Charles River Laboratories
Covance
Cyprotex
Drumetix Laboratories
Eurofins Scientific
GVK Biosciences
LGC
Parexel
Pharmoptima
TCG Lifesciences
Global Pharmacokinetics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmacokinetics market, Segment by Type:
Noncompartmental Methods
Compartmental Methods
Global Pharmacokinetics market, by Application
Oncology
Cardiovascular Diseases
Infectious Diseases
Autoimmune Diseases
Respiratory Disorders
Neurological Disorders
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmacokinetics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Pharmacokinetics is a branch of pharmacology dedicated to determining the fate of substances administered to a living organism.
The global Pharmacokinetics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pharmacokinetics in various end use industries. The expanding demands from the Oncology, Cardiovascular Diseases, Infectious Diseases and Autoimmune Diseases, are propelling Pharmacokinetics market. Noncompartmental Methods, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Compartmental Methods segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmacokinetics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmacokinetics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmacokinetics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmacokinetics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmacokinetics covered in this report include Charles River Laboratories, Covance, Cyprotex, Drumetix Laboratories, Eurofins Scientific, GVK Biosciences, LGC, Parexel and Pharmoptima, etc.
The global Pharmacokinetics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Charles River Laboratories
Covance
Cyprotex
Drumetix Laboratories
Eurofins Scientific
GVK Biosciences
LGC
Parexel
Pharmoptima
TCG Lifesciences
Global Pharmacokinetics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmacokinetics market, Segment by Type:
Noncompartmental Methods
Compartmental Methods
Global Pharmacokinetics market, by Application
Oncology
Cardiovascular Diseases
Infectious Diseases
Autoimmune Diseases
Respiratory Disorders
Neurological Disorders
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmacokinetics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pharmacokinetics
1.1 Pharmacokinetics Market Overview
1.1.1 Pharmacokinetics Product Scope
1.1.2 Pharmacokinetics Market Status and Outlook
1.2 Global Pharmacokinetics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pharmacokinetics Market Size by Region (2018-2029)
1.4 Global Pharmacokinetics Historic Market Size by Region (2018-2023)
1.5 Global Pharmacokinetics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pharmacokinetics Market Size (2018-2029)
1.6.1 North America Pharmacokinetics Market Size (2018-2029)
1.6.2 Europe Pharmacokinetics Market Size (2018-2029)
1.6.3 Asia-Pacific Pharmacokinetics Market Size (2018-2029)
1.6.4 Latin America Pharmacokinetics Market Size (2018-2029)
1.6.5 Middle East & Africa Pharmacokinetics Market Size (2018-2029)
2 Pharmacokinetics Market by Type
2.1 Introduction
2.1.1 Noncompartmental Methods
2.1.2 Compartmental Methods
2.2 Global Pharmacokinetics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pharmacokinetics Historic Market Size by Type (2018-2023)
2.2.2 Global Pharmacokinetics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmacokinetics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pharmacokinetics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pharmacokinetics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pharmacokinetics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pharmacokinetics Revenue Breakdown by Type (2018-2029)
3 Pharmacokinetics Market Overview by Application
3.1 Introduction
3.1.1 Oncology
3.1.2 Cardiovascular Diseases
3.1.3 Infectious Diseases
3.1.4 Autoimmune Diseases
3.1.5 Respiratory Disorders
3.1.6 Neurological Disorders
3.1.7 Others
3.2 Global Pharmacokinetics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pharmacokinetics Historic Market Size by Application (2018-2023)
3.2.2 Global Pharmacokinetics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmacokinetics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pharmacokinetics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pharmacokinetics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pharmacokinetics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pharmacokinetics Revenue Breakdown by Application (2018-2029)
4 Pharmacokinetics Competition Analysis by Players
4.1 Global Pharmacokinetics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmacokinetics as of 2022)
4.3 Date of Key Players Enter into Pharmacokinetics Market
4.4 Global Top Players Pharmacokinetics Headquarters and Area Served
4.5 Key Players Pharmacokinetics Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmacokinetics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Charles River Laboratories
5.1.1 Charles River Laboratories Profile
5.1.2 Charles River Laboratories Main Business
5.1.3 Charles River Laboratories Pharmacokinetics Products, Services and Solutions
5.1.4 Charles River Laboratories Pharmacokinetics Revenue (US$ Million) & (2018-2023)
5.1.5 Charles River Laboratories Recent Developments
5.2 Covance
5.2.1 Covance Profile
5.2.2 Covance Main Business
5.2.3 Covance Pharmacokinetics Products, Services and Solutions
5.2.4 Covance Pharmacokinetics Revenue (US$ Million) & (2018-2023)
5.2.5 Covance Recent Developments
5.3 Cyprotex
5.3.1 Cyprotex Profile
5.3.2 Cyprotex Main Business
5.3.3 Cyprotex Pharmacokinetics Products, Services and Solutions
5.3.4 Cyprotex Pharmacokinetics Revenue (US$ Million) & (2018-2023)
5.3.5 Drumetix Laboratories Recent Developments
5.4 Drumetix Laboratories
5.4.1 Drumetix Laboratories Profile
5.4.2 Drumetix Laboratories Main Business
5.4.3 Drumetix Laboratories Pharmacokinetics Products, Services and Solutions
5.4.4 Drumetix Laboratories Pharmacokinetics Revenue (US$ Million) & (2018-2023)
5.4.5 Drumetix Laboratories Recent Developments
5.5 Eurofins Scientific
5.5.1 Eurofins Scientific Profile
5.5.2 Eurofins Scientific Main Business
5.5.3 Eurofins Scientific Pharmacokinetics Products, Services and Solutions
5.5.4 Eurofins Scientific Pharmacokinetics Revenue (US$ Million) & (2018-2023)
5.5.5 Eurofins Scientific Recent Developments
5.6 GVK Biosciences
5.6.1 GVK Biosciences Profile
5.6.2 GVK Biosciences Main Business
5.6.3 GVK Biosciences Pharmacokinetics Products, Services and Solutions
5.6.4 GVK Biosciences Pharmacokinetics Revenue (US$ Million) & (2018-2023)
5.6.5 GVK Biosciences Recent Developments
5.7 LGC
5.7.1 LGC Profile
5.7.2 LGC Main Business
5.7.3 LGC Pharmacokinetics Products, Services and Solutions
5.7.4 LGC Pharmacokinetics Revenue (US$ Million) & (2018-2023)
5.7.5 LGC Recent Developments
5.8 Parexel
5.8.1 Parexel Profile
5.8.2 Parexel Main Business
5.8.3 Parexel Pharmacokinetics Products, Services and Solutions
5.8.4 Parexel Pharmacokinetics Revenue (US$ Million) & (2018-2023)
5.8.5 Parexel Recent Developments
5.9 Pharmoptima
5.9.1 Pharmoptima Profile
5.9.2 Pharmoptima Main Business
5.9.3 Pharmoptima Pharmacokinetics Products, Services and Solutions
5.9.4 Pharmoptima Pharmacokinetics Revenue (US$ Million) & (2018-2023)
5.9.5 Pharmoptima Recent Developments
5.10 TCG Lifesciences
5.10.1 TCG Lifesciences Profile
5.10.2 TCG Lifesciences Main Business
5.10.3 TCG Lifesciences Pharmacokinetics Products, Services and Solutions
5.10.4 TCG Lifesciences Pharmacokinetics Revenue (US$ Million) & (2018-2023)
5.10.5 TCG Lifesciences Recent Developments
6 North America
6.1 North America Pharmacokinetics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pharmacokinetics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmacokinetics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmacokinetics Market Dynamics
11.1 Pharmacokinetics Industry Trends
11.2 Pharmacokinetics Market Drivers
11.3 Pharmacokinetics Market Challenges
11.4 Pharmacokinetics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
